Enovis Corporation (CFX)
NYSE · Healthcare
Enovis Corporation Income Statement 2018–2021
| Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenue | 3.85B | 3.07B | 3.33B | 3.67B |
| Gross Profit | 1.61B | 1.29B | 1.40B | 1.13B |
| Profitability | ||||
| Operating Income | 284.3M | 200.7M | 268.9M | 314.6M |
| EBITDA | 558.4M | 446.9M | 471.3M | 456.5M |
| Net Income | 76.3M | 45.8M | -517.1M | 154.5M |
| Per Share Data | ||||
| EPS (diluted) | — | $0.93 | $-11.67 | $3.48 |
| Shares Outstanding (dil.) | — | 46M | 45M | 40M |
Enovis Corporation Income Statement — FAQ
Enovis Corporation (CFX) income statement over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CFX's income statement history?
The chart and table above show Enovis Corporation's income statement by year and by quarter, including the growth rate.